Valentine et al. (1967) described a child with anemia present from birth and deficiency of red cell hexokinase. The father and one sib had low levels. The mother's level was also low but within the range of normal. ... Valentine et al. (1967) described a child with anemia present from birth and deficiency of red cell hexokinase. The father and one sib had low levels. The mother's level was also low but within the range of normal. The deficiency apparently did not involve leukocytes and platelets and was different from the hexokinase deficiency identified in Fanconi pancytopenia (227650). Necheles et al. (1970) found, however, associated deficiency of leukocyte hexokinase. Rijksen and Staal (1978) studied a patient with hemolytic anemia due to hexokinase deficiency and showed that the mutant enzyme had abnormal electrophoretic properties and abnormal behavior with respect to its regulation by glucose-1,6-diphosphate and inorganic phosphate. They proposed that there are two different hexokinases type I in red cells, only one of which was mutant in this case. Rijksen et al. (1983) reported a girl, born of consanguineous parents, with neonatal jaundice and transfusion-dependent hemolytic anemia. Residual HK1 activity in the patient's red cells and platelets was about 25% of normal, consistent with hexokinase deficiency. In lymphocytes, HK activity was normal; HK1 was low but the deficiency was compensated by HK3 (142570). The parents and 3 sibs were apparent heterozygotes, as demonstrated by 50 to 67% residual activity in their red cells, but they had no clinical signs of hexokinase deficiency. The patient's mutant enzyme showed a 2-fold decrease in affinity for Mg-ATP2 and a markedly decreased affinity for the inhibitor glucose-1,6-diphosphate. Paglia et al. (1981) found a low activity isozyme of red cell hexokinase in a Chinese boy with chronic hemolytic anemia. Because of subtle differences between the hexokinases of the parents, it was proposed that the proband might be a compound heterozygote.
Bianchi and Magnani (1995) reported the molecular characterization of the defect in HK1 in a patient with hemolytic anemia due to hexokinase deficiency. PCR amplification and sequence of the cDNA revealed compound heterozygosity for a deletion and a ... Bianchi and Magnani (1995) reported the molecular characterization of the defect in HK1 in a patient with hemolytic anemia due to hexokinase deficiency. PCR amplification and sequence of the cDNA revealed compound heterozygosity for a deletion and a single nucleotide substitution. The 96-bp deletion (142600.0001) involved nucleotides 577 to 672 of their cDNA sequence and was found in the cDNA of none of 14 unrelated normal subjects. The sequence of the HK1 allele without deletion showed a T-to-C transition of nucleotide 1677, which caused the amino acid change leu529-to-ser (142600.0002). The substitution was not found in 10 normal controls. Bianchi and Magnani (1995) stated that to their knowledge only 14 cases had been described, 2 of which had been studied in their laboratory: HK-Melzo and HK-Napoli. It was in HK-Melzo in which the molecular defect was demonstrated. They showed that in the HK-Melzo variant, the HK deficiency was expressed not only in erythrocytes but also in platelets, lymphocytes, and fibroblasts. All these types of cells contain HK type 1 as the predominant glucose phosphorylating enzyme and, in particular, platelets and erythrocytes share a strict dependence upon glucose utilization for their physiologic In a girl with severe nonspherocytic hemolytic anemia due to hexokinase deficiency previously reported by Rijksen et al. (1983), van Wijk et al. (2003) identified a homozygous mutation in the HK1 gene (T680S; 142600.0004). The mutation segregated with the disorder in the family and was not found in 50 controls.